FORM DEF 14A

Company

IGC Pharma, Inc.

Filed

July 25, 2022

Period of Report

September 9, 2022

Accession Number

0001185185-22-000846

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →